Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Innospec (IOSP) EBITDA (2016 - 2025)

Historic EBITDA for Innospec (IOSP) over the last 17 years, with Q3 2025 value amounting to $5.9 million.

  • Innospec's EBITDA fell 8706.14% to $5.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $123.8 million, marking a year-over-year decrease of 3171.54%. This contributed to the annual value of $177.9 million for FY2024, which is 1008.66% up from last year.
  • Latest data reveals that Innospec reported EBITDA of $5.9 million as of Q3 2025, which was down 8706.14% from $34.3 million recorded in Q2 2025.
  • Innospec's 5-year EBITDA high stood at $50.5 million for Q1 2024, and its period low was $5.9 million during Q3 2025.
  • Over the past 5 years, Innospec's median EBITDA value was $41.1 million (recorded in 2024), while the average stood at $39.0 million.
  • In the last 5 years, Innospec's EBITDA skyrocketed by 16928.84% in 2021 and then crashed by 8706.14% in 2025.
  • Quarter analysis of 5 years shows Innospec's EBITDA stood at $35.5 million in 2021, then skyrocketed by 31.27% to $46.6 million in 2022, then decreased by 4.51% to $44.5 million in 2023, then decreased by 7.64% to $41.1 million in 2024, then plummeted by 85.64% to $5.9 million in 2025.
  • Its EBITDA stands at $5.9 million for Q3 2025, versus $34.3 million for Q2 2025 and $42.5 million for Q1 2025.